Insider Transactions in Q2 2024 at Spring Works Therapeutics, Inc. (SWTX)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 03
2024
|
Badreddin Edris Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
20,000
-1.9%
|
$800,000
$40.86 P/Share
|
|
Jun 03
2024
|
Julie Hambleton Director |
SELL
Open market or private sale
|
Direct |
4,648
-16.4%
|
$185,920
$40.89 P/Share
|
|
Jun 03
2024
|
Saqib Islam Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
49,000
-1.07%
|
$1,960,000
$40.87 P/Share
|
|
May 16
2024
|
Freda C Lewis Hall Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,095
+21.83%
|
-
|
|
May 16
2024
|
Daniel Lynch Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,095
+1.32%
|
-
|
|
May 16
2024
|
Carlos Alban Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,095
+17.89%
|
-
|
|
May 16
2024
|
Alan Fuhrman Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,095
+21.83%
|
-
|
|
May 16
2024
|
Julie Hambleton Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,095
+31.9%
|
-
|
|
Apr 01
2024
|
Bhavesh Ashar Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,824
-3.14%
|
$85,728
$47.62 P/Share
|